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MutagenesisMutations in the BCL-6 corepressor (BCOR) gene, which encodes a transcriptional corepressor, were
described to cause oculofaciocardiodental syndrome (MIM 300166). The purpose of this study was to
localize the classical nuclear localization signals (NLSs) of the BCOR using reported human BCOR
mutations with comparable phenotypes. The genotype–phenotype correlation among the mutations
could not be clearly explained; however, the classical NLSs were identiﬁed at two possible sites;
RVDRKRKVSGD at aa1131–1141 (NLS1) and LKAKRRRVSK at aa1158–1167 (NLS2). In addition,
according to our results, NLS2 displayed a more efﬁcient nuclear import function than NLS1.
 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction can interact with a variety of corepressors via several domains.Oculofaciocardiodental syndrome (OFCD; MIM 300166) is a rare
disorder characterized by microphthalmia, congenital cataracts,
facial dysmorphic features, congenital heart defects, and dental
anomalies [1–6]. This syndrome is an X-linked dominant,
male-speciﬁc lethal with skewed X inactivation in heterozygous
female individuals [1,7]. Mutations in the BCL-6 corepressor
(BCOR) gene were described to cause OFCD syndrome [3]. Many
mutations in the BCOR gene have been reported in OFCD patients.
The reported mutations were dispersed along the entire 15 exons
of the BCOR gene and most of these mutations were predicted to
generate premature stop codons (PTCs). Regardless of the mutation
site, all patients have similar typical OFCD phenotypes, but differ in
severity even in single families with the same mutation [8].
The BCOR gene was ﬁrst identiﬁed as a corepressor that inter-
acts speciﬁcally with the POZ domain of BCL-6 [9]. BCL-6 belongs
to subclass of zinc ﬁnger proteins with a POZ/BTB domain at the
N terminus and Cys2-His2-zinc ﬁngers at the C terminus. BCL-6The central domain of BCL-6 recruits the corepressor MTA3 and
its associated HDAC-containing chromatin remodeling complex
(Mi-2/NuRD) [10]. The POZ domain of BCL-6 interacts with many
corepressors; NCOR, SMRT, and BCOR in a mutually exclusive fash-
ion [9]. BCOR complex contains Polycomb group (PcG) proteins,
including a histone H2A ubiquitin E3 ligase and an SCF ubiquitin
E3 ligase. It is also able to associate with a JmiC domain histone
H3 K36 demethylase-containing protein. The enzymatic activities
of the BCOR complex, through epigenetic modiﬁcations of chro-
matin, provide a mechanism for silencing of BCL-6 targets, includ-
ing P53 (TP53) and Cyclin D2 (CCND2) [10].
The BCOR gene is expressed as several alternatively spliced
transcripts [11]. To date, the BCOR gene is known to encode at least
four important isoforms: isoform a (NP_001116855.1), isoform b
(NP_001116856.1), isoform c (NP_001116857.1), and isoform d
(Genbank: AAG41430.1). Because BCOR protein is a transcriptional
corepressor, it needs to be imported into the nucleus to execute its
proper activity. In eukaryotic cells, the genetic material and
transcriptional machinery of the nucleus are separated from the
translational machinery and metabolic systems of the cytoplasm
by the nuclear envelope. Transport of macromolecules into and
out of the nucleus occurs through large proteinaceous structures
called nuclear pore complexes. Ions and small proteins (<40kDa)
pass through the nuclear pore complexes by passive diffusion,
but larger molecules need an appropriate targeting signal.
Several pathways for nucleocytoplasmic transport have been
described, of which the classical nuclear import pathway is the
Table 1
Summary of phenotypes of seven reported mutations.
BCOR mutations Ocular Facial Cardiac Dental Others References
Mut1 c.570delC Congenital cataract
Microphthalmia
Ptosis
Septate nasal cartilage
High nasal bridge
Long and narrow face
Simple ears
Not affected Radiculomegaly
Fusion tooth
Delayed dentition
Hypodontia
Mild mental
retardation
Hilton et al. [4]
Mut2 c.2613delC Congenital cataract
Microphthalmia
Glaucoma
Ptosis
Long and narrow face
Bulbous and biﬁd nasal tip
Cup-shaped ears
Micrognathia
Orofacial clefting
Heart murmur Radiculomegaly
Fusion tooth
Impacted tooth
Delayed dentition
Oligodontia
Radioulnar synostosis
Recurrent otitis media
Oberoi et al. [6]
Mut3 c.2926C>T Congenital cataract
Microphthalmia
Ptosis
Lens dislocation
Optic disc dysplasia
Septate nasal cartilage
High nasal bridge
Broad and biﬁd nasal tip
Cleft palate
Prominent mandible
Heart murmur
ASD
VSD
Pulmonary valve
stenosis
Radiculomegaly
Fusion tooth
Impacted tooth
Tooth malposition
Hypodontia
Radioulnar synostosis
Syndactyly toes 2–3
Hammer toes
Mild hearing loss
Ng et al. [3]
Mut4 c.3286delG Congenital cataract
Microphthalmia
Ptosis
Broad nasal tip
Long philtrum
Cleft palate/biﬁd uvula
VSD Radiculomegaly
Delayed dentition
Oligodontia
Sandal gaps
Broad halluces
Camptodactyly toes 2–
3
Horn et al. [12]
Mut5 c.3427_3428insA Congenital cataract
Microphthalmia
Coloboma
Septate nasal cartilage
Simple ears
ASD
VSD
Primary dentition
unaffected
Radioulnar synostosis
Syndactyly toes 2–3
Partial fusion of
vertebrae (C2–C3)
Hilton et al. [4]
Mut6 c.3668delC Congenital cataract
Microphthalmia
Regressive vision
impairment
Broad nasal tip, separated
nasal cartilage
High nasal bridge
Long narrow face
Eyebrows laterally curved
and thick
Submucous cleft palate
Not affected Radiculomegaly
Malformed tooth
Impacted tooth
Delayed dentition
Hypodontia
Radioulnar synostosis
Hammer toes
Short 5th ﬁnger
Hearing loss
Surapornsawasd
et al. [1]
Mut7 c.4794G>A Congenital cataract
Microphthalmia
Glaucoma
Regressive vision
impairment
Separated nasal cartilage
High nasal bridge
Broad nasal tip
Long narrow face
Cleft palate
ASD
VSD
Radiculomegaly
Malformed tooth
Impacted tooth
Delayed dentition
Oligodontia
Radioulnar synostosis
Hammer toes
Hearing loss
Surapornsawasd
et al. [1]
All mutations lead to similar phenotypes. Variations in severity were observed even in the same family carrying the same mutation. ASD = atrial septal defect, VSD = ven-
tricular septal defect.
 The secondary dentition was not mentioned because the patient’s age at the time of examination was 2 years old.
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contain amino acid-targeting sequences called nuclear localization
signals (NLSs) [12]. However, the mechanisms regulating BCOR
nuclear translocation have not yet been elucidated.
The different mutations might affect BCL-6–BCOR complex for-
mation; one possible mechanism would be that the mutations
affect the total expression levels of BCOR due to PTCs inducing
non-sense mediated mRNA decay. The second, some of the
mutations might produce very short forms of the protein that do
not include the important domains for its function. And the third
possibility would be that in some of these mutant forms of BCOR,
the proper protein localization is affected, hence, it will affect the
function of the protein. Here, we showed the data that should shed
some light about the nuclear localization of BCOR among the differ-
ent reported mutations and ﬁrst localized the NLSs of the BCOR and
also identiﬁed the critical regions inside the NLSs. The classical NLSs
of the BCOR were located at two possible sites: RVDRKRKVSGD at
aa1131–1141 (NLS1) and LKAKRRRVSK at aa1158–1167 (NLS2).
2. Materials and methods
2.1. Mutagenesis
Seven reported BCOR mutations (Mut1–Mut7) [1,3,4,6,13] were
generated using a wild-type (WT) BCOR plasmid (OmicsLink™
Expression Clone Datasheet of EX-Z0986-M12, 3xFLAG, BCOR
isoform a, GeneCopoeia, Rockville, MD, USA) as the DNA template
using a Quikchange Lightning Site-Directed Mutagenesis
Kit (Agilent Technologies, La Jolla, CA, USA) according to themanufacturer’s protocol. The BCOR mutations were conﬁrmed by
conventional PCR using Takara Ex Taq Mg2+ free buffer (Takara
Holdings Inc., Kyoto, Japan) and direct sequencing with the BigDye
Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems, Life
Technologies, Foster City, CA, USA). NLS1 and NLS2 mutated plas-
mids were also generated using Mut5 and Mut6 plasmids as the
template and following the protocol as above.
2.2. Cell culture and transfection
COS7 cells were cultured in aMEM (Wako, Osaka, Japan) sup-
plemented with 10% fetal bovine serum (Gibco, Life Technologies,
Paisley, UK) and penicillin–streptomycin (Gibco). The cultures
were maintained in a humidiﬁed 5% CO2 atmosphere at 37 C.
Transfection with empty plasmid, WT, and mutant BCOR plasmids
was carried out using FuGENE 6 transfection reagent (Promega,
Madison, WI, USA) according to the manufacturer’s speciﬁcations.
After 24 h, cells were analyzed by ﬂuorescence microscopy or har-
vested for protein analysis by western blotting analysis. The exper-
iments were performed in triplicate.
2.3. Immunoblot analysis
The transfected COS7 cultures, 70–90% conﬂuent 100-mm dish,
were lysed with 1 mL of Laemmli lysis buffer containing a
Complete Mini protease inhibitor cocktail (Roche, Mannheim,
Germany), 1 tablet per 10 mL lysis buffer. Proteins were loaded
into 7.5% SDS–polyacrylamide gels, separated by electrophoresis
and transferred onto PVDF membranes. Immobilized peptides
ab
c
Fig. 1. The position of the mutations and the mutant proteins (Mut1–Mut7). (a) The positions of the seven reported mutations. (b) The positions of the mutant proteins. (c) All
mutant proteins generated from mutagenesis were detected by immunoblotting, clearly separated in different sizes. b-Actin was used as a positive control.
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anti-FLAG M2 (Sigma–Aldrich, Saint Louis, MO, USA) for 2.5 h,
and then incubated with a 1:2000 dilution of a goat anti-mouse
IgG-HRP-labeled antibody (Santa Cruz Biotechnology, Santa Cruz,
CA, USA) for 1 h. To detect b-actin as a positive control, immobi-
lized peptides from cellular extracts were incubated with a 1:200
dilution of a mouse monoclonal anti-b-actin antibody (Santa Cruz
Biotechnology) for 2.5 h, and incubated with a 1:1000 dilution of
a goat anti-mouse IgG-HRP-labeled antibody (Santa Cruz Biotech-
nology) for 1 h. Detection was performed using ECL™ Prime Wes-
tern blotting detection reagent (GE Healthcare, Buckinghamshire,
UK). Images were taken with a CCD camera in a LAS-4000 mini
luminescent image analyzer (Fujiﬁlm, Tokyo, Japan).2.4. Immunoﬂuorescence
COS7 cells were cultured on Lab-Tek II Chamber Slides (Thermo
Fisher Scientiﬁc Inc., Rochester, NY, USA) to 70% conﬂuency at the
time of transfection. Following 24 h of incubation, cells were ﬁxed
in 10 C methanol for 5 min, blocked with 10% goat serum in
PBST for 20 min, and then probed with a 1:1000 dilution of mouse
monoclonal anti-FLAG M2 (Sigma–Aldrich) for 60 min and a
1:1000 dilution of goat anti-mouse IgG-FITC (Santa Cruz Biotech-
nology) for 45 min as the ﬁrst and second antibodies, respectively.
All slides were mounted with Prolong Gold antifade reagent with
DAPI (Life Technologies, Carlsbad, CA, USA) and examined by using
a Leica AF6000 ﬂuorescence microscope (Leica Microsystems,
ab
Fig. 2. Subcellular localization of the mutant proteins. (a) Empty plasmid and WT
BCOR were used as negative and positive controls, respectively. WT BCOR protein
was expressed mainly in the nucleus of the cell. Mut2, 3, and 4 proteins were
expressed mainly in the cytoplasm, while Mut6 and 7 proteins were expressed
intensely in the nucleus like the WT. Mut1 and 5 proteins were expressed both in
the cytoplasm and nucleus of the transfected cells. (b) The ﬂuorescence nucleus/cy-
toplasm ratio. WT = wild type.
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formed in triplicate. The ﬂuorescence intensity in the nucleus and
cytoplasm compartments of 30 randomly selected cells was mea-
sured and compared using ImageJ software. The ﬂuorescence
nucleus/cytoplasm ratio in each mutation was calculated. If the
ratio was more than 1 then the expression of the protein was
mainly in the nucleus of the cell. If the ratio was less than 1 then
the expression of the protein was mainly in the cytoplasm. If the
ratio was nearly 1, the expression in both nucleus and cytoplasm
was likely equal.
2.5. NLS program analysis
NLS mapper [14] (http://nls-mapper.iab.keio.ac.jp/cgi-bin/NLS_
Mapper_form.cgi) and PSORTII (http://psort.hgc.jp/form2.html)
programs were used for analysis of the possible NLS sites.
3. Results
3.1. Clinical phenotypes of seven reported mutations
Summary information about the mutations is shown in
Table 1. Typical OFCD phenotypes were detected in all affected
patients but differed in severity, even in the same family. The
genotype-phenotype correlation was difﬁcult to identify.
3.2. Mutant protein expression
The positions of the seven mutations and the mutant proteins
are shown in Fig. 1a and b. All mutant proteins generated from
mutagenesis were detected by immunoblotting, and were clearly
distinguishable by their different sizes (Fig. 1c).
3.3. Subcellular localization of the seven reported mutant proteins
All mutant proteins and WT BCOR protein were detected by
immunoﬂuorescence. The WT BCOR protein was expressed mainly
in the nucleus of the cell. The Mut2, 3, and 4 proteins were
expressed mainly in the cytoplasm while the Mut6 and 7 proteins
were expressed intensely in the nucleus, similar to the WT. Inter-
estingly, the Mut1 and 5 proteins were expressed both in the cyto-
plasm and nucleus of the transfected cells. These results are shown
in Fig. 2a and b. The amino acid sequences between Mut4 and
Mut6 were analyzed with NLS mapper and PSORT II for the possi-
ble NLS sites. The result from these two programs (data not shown)
revealed two possible NLS sites, RVDRKRKVSGD at aa1131–1141
(NLS1) and LKAKRRRVSK at aa1158–1167 (NLS2). These two sites
are conserved, at least in primates (Fig. 3a). According to these
two sites, the Mut1, 2, 3, and 4 proteins carry neither NLS1 nor
NLS2, the Mut5 protein carries only NLS1 and the Mut6 and 7 pro-
teins carry both NLS1 and NLS2 (Fig. 3b).
3.4. Basic amino acid residues affecting nuclear localization
According to the orthologs and the PSORT II program, conserved
sequences in NLS1 (RKRK) and NLS2 (KRRR) were found. Previous
studies have shown that these sequences were identiﬁed as a short
cluster of basic amino acid residues within the NLS [15,16]. They
are located at amino acids 1134–1137 and 1161–1164. To deter-
mine which amino acid residue is responsible for the critical
regions of NLS1 and NLS2 in the BCOR protein, site-directed muta-
genesis was performed within the Mut5 and Mut6 plasmids,
respectively (Figs. 4a and 5a). As shown in Fig. 4b and c, mutation
of any of the KRKR amino acid residues at aa1134–1137
(NLS1D2–D5) in Mut5 severely disrupted the nuclear localization
a 
b 
Fig. 3. The possible NLS sites. (a) The orthologs of BCOR protein at aa1125–1175. (b) The summary scheme of subcellular localization.
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According to Fig. 5b and c, mutation of any of the KRRR amino acid
residues at aa1161–1164 (NLS2D2–D5) in Mut6 increased protein
diffusion in the cytoplasmic compartment of the transfected cells;
however, the result was still showing that the mutant proteins
expressed mainly in the nuclear compartment as shown in
Fig. 5c, all ratios were above 1. As controls, mutations of amino acid
residues ﬂanking KRKR or KRRR did not affect the nuclear localiza-
tion of Mut5 and Mut6.
3.5. The nuclear localization function of NLS2
NLS1 is not sufﬁcient for perfect nuclear transport of the BCOR
protein, as shown in the Mut5 immunoﬂuorescence result. To
determine whether NLS2 alone can function for complete transport
of BCOR protein into the nucleus, we generated NLS1 critical region
mutations in the Mut6 plasmid, L-NLS1D2, L-NLS1D3, and
L-NLS1D4 (Fig. 6a). The results show that if NLS1 function is dis-
rupted while NLS2 is intact, the protein can be transported into
the nucleus and expressed mainly in the nucleus compartment
(Fig. 6b and c).
4. Discussion
The nucleus, a specialized compartment for DNA separated
from the rest of the cell by a membranous nuclear envelope in
eukaryotic cells, establishes a connection between the nuclear
transport machinery and the transcriptional apparatus. The cyto-
plasm and the nucleus intercommunicate via nuclear pore com-
plexes, which are large transporters running through the nuclear
membrane. Ions and small neutral proteins (<40kDa) pass through
these complexes by passive diffusion. Therefore, the Mut1 protein
(22.91kDa) can likely pass through the nuclear pore complex and
be expressed in both the cytoplasm and nucleus.
Proteins involved in transcription and its regulation in response
to distinct physiological conditions must be expressed in the
nucleus to fulﬁll their functions [17]. Furthermore, BCOR is atranscriptional corepressor. Its main function occurs in the
nucleus, so the transport of the BCOR protein after translation in
the cytoplasm back into nucleus is very critical. Any protein that
is not transported into the nucleus can be assumed to be
non-functional. The best understood system for the transport of
macromolecules between the cytoplasm and the nucleus is the
classical nuclear import pathway. The ﬁrst step of classical nuclear
import occurs when importin-a discriminates between its cargo
and other cellular proteins via the NLSs. According to the various
BCOR isoforms, as well as our results for subcellular expression of
mutant proteins and program analysis, the classical NLSs of the
BCOR protein are located at two possible sites; RVDRKRKVSGD at
aa1131–1141 (NLS1) and LKAKRRRVSK at aa1158–1167 (NLS2).
Mutant proteins carrying neither NLS1 nor NLS2 are expressed
mainly in cytoplasm. However, a mutant carrying only the NLS1
site was not sufﬁcient for perfect transport of the protein into
the nucleus. Complete transport of the protein was only detected
when the protein contained both NLS1 and NLS2, or at least the
intact NLS2. According to our results, the critical regions of NLS1
were the amino acid residues KRKR at aa1134–1137. The critical
regions of NLS2 were more difﬁcult to identify, but likely to be
amino acid residues KRRR at aa1161–1164 that showed the lower
ﬂuorescence nucleus/cytoplasm ratio as shown in Fig. 5c. However,
the protein expressions were mainly in the nucleus, cytoplasmic
protein diffusion was detected more abundantly in NLS2D2–D5.
A previous study showed that depending on the structure and
characteristics of the mutant amino acid sequence, the binding
afﬁnity in the critical region in the NLS might be affected in a dif-
ferent manner [18]. Further studies are needed to clarify this
mechanism.
To date, most of the reported BCOR mutations result in
premature termination of the protein with deletion of the
carboxy-terminal domain [1,3,6,13]. It was reported that truncated
BCOR protein in affected patients displayed repressor effects
equivalent to those of WT BCOR [3]. Therefore, we hypothesize
the following: very small proteins (<40kDa) are too small to func-
tion and are degraded because of instability, even though they can
ab
c
Fig. 4. Basic amino acid residues affected the NLS1. (a) Mut5 was used as the
template to generate mutations inside the NLS1. (b) Mutation of any amino acid
residue of KRKR at aa1134–1137 (NLS1D2–D5) severely disrupted the nuclear
localization of the BCOR protein and led to a diffuse cytoplasmic distribution. As a
control, mutation of amino acid residues ﬂanking KRKR (NLS1D1 and D6) did not
affect the nuclear localization of Mut5. (c) The ﬂuorescence nucleus/cytoplasm
ratio.
a
b
ig. 5. Basic amino acid residues affected the NLS2. (a) Mut6 was used as the
mplate to generate mutations inside the NLS2. (b) Although the mutation of any
mino acid residue of KRRR at aa1161–1164 (NLS2D2–D5) led to increased protein
iffusion into the cytoplasmic compartment of the transfected cells, the result was
ill showing that mutant protein expressions were mainly in the nuclear
mpartment. As a control, mutation of amino acid residues ﬂanking KRRR
LS2D1 and D6) did not affect the nuclear localization of Mut6. (c) The
uorescence nucleus/cytoplasm ratio.
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nuclear and cytoplasmic compartments. Proteins that do not con-
tain NLS1 or NLS2 would not be transported into the nucleus andF
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a
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ﬂcould not function as transcriptional corepressors. Truncated pro-
teins containing only NLS1 can partially be transported into the
nucleus and might have partial function. Truncated proteins con-
taining at least an intact NLS2 might be able to be normally trans-
ported into the nucleus and function; however, before translation
into protein, mutant mRNA carrying a premature stop codon could
be degraded by the non-sense-mediated mRNA decay mechanism,
causing dramatically decreased mRNA levels and substantially
decreased translation. It is likely that mutant cells would be hap-
loinsufﬁcient for WT BCOR protein, leading to typical OFCD condi-
tions in BCOR-sensitive tissues.
Both NLS1 and NLS2 were possible sites as determined by pro-
gram analysis and also were reported previously to have a certain
nuclear transport function [15,16]. Multiple NLSs might afford
redundancy in proteins that require nuclear import, each NLS
Fig. 6. The nuclear import function of independent NLS2 when NLS1 was disrupted. (a) Mut6 was used as the template to generate mutations inside the NLS1 (L-NLS1D2,
L-NLS1D3, and L-NLS1D4). (b) The result showed that all mutant proteins were expressed mainly in the nucleus. (c) The ﬂuorescence nucleus/cytoplasm ratio.
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ate with one another and allow more efﬁcient import. Possible
variations of cooperation between multiple NLSs may allow ﬁne
control of nuclear import under various conditions [18]. In our
study, NLS2 displayed a stronger nuclear import function than
NLS1. Besides the amino acid sequences of the NLS, the
three-dimensional conformation of the protein containing the
NLS contributes to promote the speciﬁc binding of importin-a to
the substrate [19]. Hence, the BCOR protein structure and the bind-
ing afﬁnity of the NLSs to importin-a needs further study to clarify
the relationship between NLS1 and NLS2.
To evaluate NLSs, deletion mutations within the gene of interest
are typically generated and protein expression conﬁrmed by
immunoﬂuorescence or immunoblotting. In our study, we did
not perform the deletion method but instead generated mutations
that were reported previously in different sites in the BCOR gene, to
compare the clinical phenotypes and hopefully to identify a
genotype-phenotype correlation. According to many previousstudies, all mutations in the BCOR gene lead to similar phenotypes,
but variations in severity were observed even in the same family
carrying the same mutation. Therefore, the genotype-phenotype
correlation is very complex and cannot explained by the mutation
site alone. Other factors, such as mosaicism from X inactivation
patterns and different sensitivities in the protective mechanisms
in individuals might be involved in the severity of this syndrome.
In summary, although the genotype–phenotype correlation
among the mutations could not be clearly explained, the classical
NLSs were identiﬁed. Our study suggests that these two classical
NLS sites are necessary for the perfect nuclear transport system
of the BCOR protein. Further study will be needed to clarify the
relationship between NLS1 and NLS2.
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